Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E23.28 EPS (ttm)5.55 Insider Own0.07% Shs Outstand2.98B Perf Week-11.10%
Market Cap385.00B Forward P/E14.98 EPS next Y8.62 Insider Trans-20.55% Shs Float2.68B Perf Month-10.47%
Income15.14B PEG3.00 EPS next Q1.95 Inst Own68.60% Short Float0.62% Perf Quarter-7.73%
Sales81.38B P/S4.73 EPS this Y-8.50% Inst Trans0.50% Short Ratio1.92 Perf Half Y6.45%
Book/sh24.09 P/B5.36 EPS next Y5.56% ROA1.00% Target Price148.56 Perf Year-8.83%
Cash/sh6.50 P/C19.88 EPS next 5Y7.76% ROE2.50% 52W Range118.62 - 148.99 Perf YTD-7.57%
Dividend3.60 P/FCF42.16 EPS past 5Y7.10% ROI15.70% 52W High-12.46% Beta0.57
Dividend %2.79% Quick Ratio1.40 Sales past 5Y2.60% Gross Margin66.50% 52W Low9.95% ATR3.79
Employees134000 Current Ratio1.70 Sales Q/Q3.60% Oper. Margin21.40% RSI (14)28.01 Volatility3.87% 2.35%
OptionableYes Debt/Eq0.48 EPS Q/Q4.90% Profit Margin1.90% Rel Volume2.70 Prev Close129.14
ShortableYes LT Debt/Eq0.46 EarningsJan 15 BMO Payout526.10% Avg Volume8.73M Price130.42
Recom2.30 SMA20-9.45% SMA50-7.92% SMA200-1.46% Volume23,550,878 Change0.99%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Dec-18-18 04:44PM  US STOCKS-S&P flat as government shutdown threat, Fed decision loom Reuters
04:26PM  Dow Closes Positive as Stocks Buffeted by Volatile Tuesday Trading
03:14PM  Plunging oil prices pull energy stocks lower, erasing gains Associated Press
03:00PM  Dow Jones Today: Boeing Spikes On Dividend News; Nike Rises Ahead Of Results Investor's Business Daily
01:56PM  What's In Store for GE in 2019? & Tuesday's Trending Stocks: TLRY, JNJ, ORCL Zacks
01:27PM  Final Trades: Automatic Data, Alaska Air, J&J, Amazon CNBC Videos
12:58PM  US STOCKS-Wall St propped up by tech stocks, financials rise ahead of Fed Reuters
11:57AM  US STOCKS-Tech stocks help Wall St rebound, financials rise ahead of Fed Reuters
11:05AM  Johnson & Johnson's $5 billion stock buyback represents 'tangible action' to back up statements of confidence MarketWatch
10:55AM  Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead? Zacks
10:34AM  Johnson & Johnson Stock Bounces Back After the Company Reaffirms Guidance
10:32AM  US STOCKS-Tech stocks, upbeat earnings boost Wall St; Fed in focus Reuters
10:03AM  Attorney behind a huge talc verdict: J&J's stock drop 'serves my purposes' in seeking a settlement CNBC
10:00AM  Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study Zacks
09:52AM  Jim Cramer: Playing the Markets, Oracle, Johnson & Johnson
09:37AM  Here Are Biotechs Big Pipeline Disappointments in 2018 Motley Fool
09:35AM  [$$] Stocks to Watch: Rent-A-Center, CBS, Boeing, Johnson & Johnson, Oracle, Red Hat The Wall Street Journal
09:23AM  J&J Okays $5B Stock Buyback Plan, Stock Remains Stressed Zacks
09:10AM  Under Armour Tanks on Guidance Motley Fool
09:02AM  US STOCKS-Wall St set to bounce from sell-off, Fed in focus Reuters
08:44AM  Attorney behind Johnson & Johnson lawsuit speaks out CNBC Videos
07:51AM  Stocks making the biggest moves premarket: DRI, FDS, NAV, ORCL, JNJ & more CNBC
07:18AM  Three Megacaps Give the Market an Early Xmas Gift: Taking Stock Bloomberg
07:11AM  Federal Reserve, Oracle, T-Mobile, Les Moonves and J&J - 5 Things You Must Know
07:00AM  Market Morning: Bear Market Overview, J&J Fights Back, Facebook Gets Stern Letter, Moonves Out to Dry Market Exclusive
05:39AM  Indian regulator says Reuters report on J&J baby powder 'under consideration' Reuters
02:38AM  J&J moves to limit impact of Reuters report on asbestos in Baby Powder Reuters
Dec-17-18 07:56PM  J&J moves to limit impact of Reuters report on asbestos in Baby Powder Reuters
07:49PM  [$$] J&J Slammed by Concern Over Baby Powder Safety The Wall Street Journal
07:20PM  Peeling Back the Band-Aid: Johnson & Johnson
07:12PM  Cramer Remix: Johnson & Johnson has to stop dropping for ... CNBC Videos
07:01PM  Johnson & Johnson CEO: 'We unequivocally believe' our bab... CNBC Videos
07:00PM  Cramer Remix: Johnson & Johnson has to stop dropping for the market to head higher CNBC
06:54PM  CNBC Exclusive: CNBC Transcript: Johnson & Johnson Chairman and CEO Alex Gorsky Speaks with CNBC's Jim Cramer Today CNBC
06:43PM  Four things need to happen for the stock market to bottom... CNBC Videos
06:41PM  What needs to happen for the market to bottom, according ... CNBC Videos
06:33PM  J&J moves to limit impact of Reuters report on asbestos in Baby Powder Reuters
06:22PM  Are Algos Jumping on J&J Headlines?
06:02PM  Johnson & Johnson Reaffirms Guidance, Sets $5 Billion Stock Buyback
05:59PM  [$$] J&J Slammed by Concern Over Baby Powder Safety The Wall Street Journal
05:50PM  J&J announces $5 billion share buyback after shares extend losses Reuters
05:46PM  Chart of the Day: Johnson & Johnson's Punishment Appears Overdone
05:33PM  Monday Madness: Johnson & Johnson Is Still Making Headlines
05:28PM  US STOCKS-S&P 500 hits 14-month low on economic jitters ahead of Fed meeting Reuters
05:22PM  J&J announces $5 billion share buyback after shares extend losses Reuters
05:17PM  Johnson & Johnson CEO: 'We unequivocally believe' our baby powder does not contain asbestos CNBC
05:06PM  J&J announces $5 billion share buyback after shares extend losses Reuters
04:47PM  J&J announces $5 billion share repurchase plan Reuters
04:44PM  J&J announces $5 billion share repurchase plan Reuters
04:43PM  US STOCKS-S&P 500 hits 14-month low on economic jitters ahead of Fed meeting Reuters
04:37PM  J&J to Buy Back $5 Billion in Shares After Brutal Two-Day Slide Bloomberg
04:34PM  Johnson & Johnson to buy back $5 billion in stock MarketWatch
04:31PM  J&J announces $5 billion share buyback program after report wipes out $50 billion in market value CNBC
04:28PM  Dow Plunges, Nasdaq Slides as December Worsens, Bear Market Looms
04:22PM  Johnson & Johnson Announces $5 Billion Share Repurchase Program PR Newswire
04:05PM  Dow Jones Today: Nike, Goldman Sachs, Johnson & Johnson Fall Sharply Investor's Business Daily
03:50PM  ETF Investing: Midcap Growth Stocks Help 2018's Top ETFs Investor's Business Daily
03:43PM  Johnson & Johnson Challenges Reuters' Assertions About Its Product Safety
03:06PM  US STOCKS-Wall St sinks as DoubleLine's Gundlach says stocks are in bear market Reuters
02:02PM  Johnson & Johnson shares oversold: Strategist CNBC Videos
01:35PM  Johnson & Johnson Insiders Buy Stock After Baby Powder Report
01:27PM  Nasdaq Today Makes New Low As Another Index Hits Bear Market Investor's Business Daily
11:39AM  Jim Cramer on When Johnson & Johnson Is a Buy
11:28AM  J&J shares extend losses; company defends Baby Powder as safe Reuters
11:28AM  Let's Get Real About Johnson & Johnson's Selloff and How to Play the Stock
11:05AM  Johnson & Johnson's Asbestos Woes: Experts Speak Up Benzinga
10:43AM  Johnson & Johnson Stock Presents a Buying Opportunity Amid an Overblown Selloff
10:20AM  Johnson & Johnson being treated unfairly in sell-off, say... CNBC Videos
10:20AM  Johnson & Johnson - Round 2 - More Selling Pressure
09:57AM  Jim Cramer on Johnson & Johnson, the Santa Claus Rally and the State of Gold
09:50AM  [$$] Stocks to Watch: Goldman, Best Buy, Alphabet The Wall Street Journal
09:25AM  A Johnson & Johnson Equity Stake Is Out of the Question Right Now
09:22AM  J&J Dips 10% as Reuters Says Company Knew of Asbestos in Talc Zacks
08:28AM  Interest in Johnson & Johnson Stock Dries Up Amid Baby Powder Scandal
08:13AM  Zacks Investment Ideas feature highlights: Johnson and Johnson Zacks
07:55AM  Johnson & Johnson should respond boldly to asbestos repor... CNBC Videos
07:35AM  High Water Marks Get Their Last Chance This Week: Taking Stock Bloomberg
07:34AM  Investors No Longer Trust Growth, Plus How to Play JNJ: Market Recon
07:10AM  Goldman Sachs, Oracle, J&J, Nissan and Colin Kroll - 5 Things You Must Know
07:00AM  Market Morning: Rate Hike Ahead, Obamacare Struck Down, JNJ Asbestos Scandal, Qatar Challenges Saudis Market Exclusive
Dec-16-18 06:40PM  Dow Jones Futures: The Worst Part About This Market Rally Investor's Business Daily
10:36AM  These are the U.S. stock markets biggest losers this week MarketWatch
09:30AM  Stock Market Power Rankings: Down Is the New Up Motley Fool
Dec-15-18 07:51AM  [$$] How Many More Tears at Johnson & Johnson? The Wall Street Journal
Dec-14-18 08:32PM  Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18) -10.04%
07:01PM  Jim Cramer: I Can't Tell You to Buy This Market
06:55PM  Johnson & Johnson knew of asbestos in baby powder, report says CBS News Videos
06:50PM  Negativity shouldn't stop you from careful stock-picking CNBC Videos
06:45PM  Bragar Eagel & Squire, P.C. is Investigating Johnson & Johnson (JNJ) on Behalf of Stockholders and Encourages JNJ Investors to Contact the Firm GlobeNewswire
06:42PM  Cramer on the sell-off: Negativity shouldn't stop you fro... CNBC Videos
06:21PM  Cramer on the sell-off: Negativity shouldn't stop you from careful stock-picking CNBC
06:15PM  Cramer's game plan: Bargains may not be enough to attract buyers CNBC
05:51PM  J&J hammered by report it knew of asbestos in baby powder Associated Press
05:51PM  J&J hammered by report it knew of asbestos in baby powder Associated Press
05:38PM  Cramer: When J&J continues falling on Monday it could be time to buy CNBC
05:31PM  Business Highlights Associated Press
05:26PM  Why Johnson & Johnson Stock Crashed 10% Today Motley Fool
05:24PM  Johnson & Johnson just posted its worst day since 2002 CNBC Videos
05:08PM  Hagens Berman Notifies Johnson & Johnson (JNJ) Investors of the Firm's Investigation of Possible Disclosure Violations PR Newswire
05:07PM  Commentary: J&J is a company of the 'highest integrity.' Investors overreact to asbestos report CNBC
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM